|
US568159A
(en)
|
1896-06-26 |
1896-09-22 |
|
Veneering-machine |
|
US4873192A
(en)
|
1987-02-17 |
1989-10-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Process for site specific mutagenesis without phenotypic selection
|
|
US5399493A
(en)
|
1989-06-15 |
1995-03-21 |
The Regents Of The University Of Michigan |
Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
|
|
US5061620A
(en)
|
1990-03-30 |
1991-10-29 |
Systemix, Inc. |
Human hematopoietic stem cell
|
|
US5635387A
(en)
|
1990-04-23 |
1997-06-03 |
Cellpro, Inc. |
Methods and device for culturing human hematopoietic cells and their precursors
|
|
US5460964A
(en)
|
1992-04-03 |
1995-10-24 |
Regents Of The University Of Minnesota |
Method for culturing hematopoietic cells
|
|
WO1995000657A1
(en)
|
1993-06-21 |
1995-01-05 |
The Uab Research Foundation |
Anti-sickling hemoglobin
|
|
US5409813A
(en)
|
1993-09-30 |
1995-04-25 |
Systemix, Inc. |
Method for mammalian cell separation from a mixture of cell populations
|
|
US5869039A
(en)
|
1993-10-15 |
1999-02-09 |
Institut National De La Sante Et De La Recherche Medicale |
X-linked adrenoleukodystrophy gene and corresponding protein
|
|
WO1996009385A1
(en)
|
1994-09-19 |
1996-03-28 |
Massachusetts Institute Of Technology |
Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease
|
|
US5677136A
(en)
|
1994-11-14 |
1997-10-14 |
Systemix, Inc. |
Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
|
|
US6187757B1
(en)
|
1995-06-07 |
2001-02-13 |
Ariad Pharmaceuticals, Inc. |
Regulation of biological events using novel compounds
|
|
KR100793625B1
(ko)
|
1995-09-29 |
2008-01-11 |
인디아나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 |
바이러스-매개된 dna 전달을 향상시키는 방법에 의해생산된 생존성 세포 집단 및 이를 포함하는 세포 조성물
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
US6057117A
(en)
|
1996-04-04 |
2000-05-02 |
Chiron Corporation |
Identification and use of selective inhibitors of glycogen synthase kinase 3
|
|
WO1998000542A2
(en)
|
1996-07-03 |
1998-01-08 |
Chiron Corporation |
Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia
|
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
|
FR2777909B1
(fr)
|
1998-04-24 |
2002-08-02 |
Pasteur Institut |
Utilisation de sequences d'adn de structure triplex pour le tranfert de sequences de nucleotides dans des cellules, vecteurs recombinants contenant ces sequences triplex
|
|
WO2000023567A2
(en)
|
1998-10-16 |
2000-04-27 |
Novartis Ag |
Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors
|
|
AU2183900A
(en)
|
1998-12-24 |
2000-07-31 |
Alcon Laboratories, Inc. |
Ep4 receptor agonists for treatment of dry eye
|
|
HK1048302A1
(zh)
|
1999-08-13 |
2003-03-28 |
大正制药株式会社 |
前列腺素衍生物
|
|
EP1233986A4
(en)
|
1999-11-12 |
2003-01-02 |
Baxter Biotech Tech Sarl |
HEMOGLOBIN COMPOSITIONS WITH REDUCED SIDE EFFECTS
|
|
CN1272328C
(zh)
|
1999-12-17 |
2006-08-30 |
希龙公司 |
糖元合成酶激酶3的基于吡嗪的抑制剂
|
|
ATE327751T1
(de)
|
2000-01-31 |
2006-06-15 |
Pfizer Prod Inc |
Verwendung von aktivatoren des prostaglandinrezeptores 4 zur behandlung von akuter oder chronischer niereninsuffizienz
|
|
US20020013294A1
(en)
|
2000-03-31 |
2002-01-31 |
Delong Mitchell Anthony |
Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
|
|
US6627442B1
(en)
*
|
2000-08-31 |
2003-09-30 |
Virxsys Corporation |
Methods for stable transduction of cells with hiv-derived viral vectors
|
|
WO2002088346A2
(en)
|
2001-05-01 |
2002-11-07 |
National Research Council Of Canada |
A system for inducible expression in eukaryotic cells
|
|
US7994144B2
(en)
|
2001-07-10 |
2011-08-09 |
Johnson & Johnson Research Pty, Limited |
Process for the preparation of a composition of genetically modified hematopoietic progenitor cells
|
|
AU2002348948A1
(en)
*
|
2001-11-30 |
2003-06-10 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods for administering EP2 receptors selective agonists
|
|
EP1461087A1
(en)
|
2001-12-06 |
2004-09-29 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Use of cd34+ hematopoietic progenitor cells for the treatment of cns disorders
|
|
GB2399819B
(en)
|
2001-12-24 |
2005-12-28 |
Es Cell Int Pte Ltd |
Method and lentiviral vector for transducing human embryonic stem cells
|
|
EP1471818A4
(en)
|
2002-02-04 |
2007-03-28 |
Millennium Pharm Inc |
METHOD AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISEASES USING 131, 148, 199, 12303, 13906, 15513, 17822, 302, 5677, 194, 14393, 28059, 7366, 12212, 1981, 261, 12416, 270, 1410, 137 , 1871, 13051, 1847, 1849, 15402, 340, 10217, 837, 1761, 8990 OR 13249 MOLECULES
|
|
EP2573079A3
(en)
|
2002-08-23 |
2015-03-11 |
Novartis AG |
Benzimidazole quinolinones and uses thereof
|
|
US7119200B2
(en)
|
2002-09-04 |
2006-10-10 |
Schering Corporation |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
ES2348868T3
(es)
|
2002-12-13 |
2010-12-16 |
Genetix Pharmaceuticals Inc. |
Vectores retrovirales terapeuticos para terapia genica.
|
|
JP4865541B2
(ja)
|
2003-04-08 |
2012-02-01 |
イエダ リサーチ アンド ディベロップメント カンパニー リミテッド |
化学誘引物質に対する増大させた感受性を有する幹細胞およびそれを産生および使用する方法
|
|
DE602004030105D1
(de)
|
2003-05-05 |
2010-12-30 |
Virxsys Corp |
Erhöhte transduktion mit abc-transportersubstratenhemmern
|
|
US6747037B1
(en)
|
2003-06-06 |
2004-06-08 |
Allergan, Inc. |
Piperidinyl prostaglandin E analogs
|
|
IL158868A0
(en)
|
2003-11-13 |
2004-05-12 |
Yeda Res & Dev |
Methods of generating and using stem cells enriched with immature primitive progenitor
|
|
WO2006001463A1
(ja)
|
2004-06-23 |
2006-01-05 |
Ono Pharmaceutical Co., Ltd. |
S1p受容体結合能を有する化合物およびその用途
|
|
WO2006047476A2
(en)
|
2004-10-26 |
2006-05-04 |
Allergan, Inc. |
Therapeutic and delivery methods of prostaglandin ep4 agonists
|
|
US20080021078A1
(en)
|
2006-07-18 |
2008-01-24 |
Horizon Therapeutics, Inc. |
Methods and medicaments for administration of ibuprofen
|
|
WO2007041511A2
(en)
|
2005-09-30 |
2007-04-12 |
New York University |
Hematopoietic progenitor kinase 1 for modulation of an immune response
|
|
US8076315B2
(en)
|
2005-10-14 |
2011-12-13 |
The Board Of Trustees Of The University Of Illinois |
Pharmacological treatments for sleep disorders (apnoe) with prostanoid receptor antagonists
|
|
DE102005062741A1
(de)
|
2005-12-22 |
2007-06-28 |
Bayer Schering Pharma Ag |
Fluorene und Carbazole als Liganden des EP2 Rezeptors
|
|
EP1999255A2
(en)
|
2006-03-24 |
2008-12-10 |
The Children's Medical Center Corporation |
Method to modulate hematopoietic stem cell growth
|
|
WO2007124578A1
(en)
|
2006-04-27 |
2007-11-08 |
Universite De Montreal |
Assessment and reduction of risk of graft-versus-host disease
|
|
WO2007148332A1
(en)
|
2006-06-22 |
2007-12-27 |
Yeda Resaerch And Development Co. Ltd |
Catecholamine receptor modulation
|
|
EP3824885A1
(en)
|
2006-10-20 |
2021-05-26 |
Children's Medical Center Corporation |
Method to enhance tissue regeneration
|
|
WO2008054825A2
(en)
*
|
2006-11-03 |
2008-05-08 |
Aastrom Biosciences, Inc. |
Mixed cell populations for tissue repair and separation technique for cell processing
|
|
WO2008070082A2
(en)
|
2006-12-04 |
2008-06-12 |
The Johns Hopkins University |
Stem-progenitor cell specific micro-ribonucleic acids and uses thereof
|
|
EP2094839B1
(en)
|
2006-12-08 |
2020-02-05 |
University of Rochester |
Expansion of hematopoietic stem cells
|
|
AU2008261901A1
(en)
*
|
2007-06-08 |
2008-12-18 |
University Of Virginia Patent Foundation |
Topical poloxamer formulations for enhancing microvascular flow: compositions and uses thereof
|
|
WO2010039997A2
(en)
|
2008-10-01 |
2010-04-08 |
The University Of North Carolina At Chapel Hill |
Hematopoietic protection against chemotherapeutic compounds using selective cyclin-dependent kinase 4/6 inhibitors
|
|
EP3031907B1
(en)
|
2008-11-06 |
2021-01-06 |
Indiana University Research and Technology Corporation |
Materials and methods to enhance hematopoietic stem cells engraftment procedures
|
|
EP3533445A1
(en)
|
2009-03-19 |
2019-09-04 |
Fate Therapeutics, Inc. |
Compositions comprising cyclic amp enhancers and/or ep ligands, and methods of preparing and using the same
|
|
DK2717922T3
(en)
|
2011-06-10 |
2019-01-07 |
Bluebird Bio Inc |
GENERATIVE VECTORS FOR ADDRENOLEUCODYSTROPHY AND ADDRENOMYELONE EUROPE
|
|
EP3692794A1
(en)
|
2011-09-16 |
2020-08-12 |
Baylor College of Medicine |
Targeting the tumor microenvironment using manipulated nkt cells
|
|
CA2850484C
(en)
*
|
2011-09-30 |
2021-01-26 |
Bluebird Bio, Inc. |
Compounds for improved viral transduction
|
|
EP3868888A1
(en)
*
|
2012-02-29 |
2021-08-25 |
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Retroviral transduction using poloxamers
|
|
US20150216903A1
(en)
*
|
2012-08-10 |
2015-08-06 |
Bluebird Bio, Inc. |
Compounds for improved viral transduction
|
|
ES2708948T3
(es)
|
2012-11-27 |
2019-04-12 |
Childrens Medical Ct Corp |
Elementos reguladores distales de bcl11a como dianas para la reinducción de la hemoglobina fetal
|
|
EP3027204B1
(en)
|
2013-07-29 |
2022-01-05 |
2seventy bio, Inc. |
Multipartite signaling proteins and uses thereof
|
|
ES2747951T3
(es)
|
2013-10-24 |
2020-03-12 |
Ospedale San Raffaele Srl |
Método
|
|
JP6412579B2
(ja)
|
2014-01-10 |
2018-10-24 |
シリオン・バイオテック・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
偽型レンチウイルスベクター
|
|
GB201407322D0
(en)
|
2014-04-25 |
2014-06-11 |
Ospedale San Raffaele |
Gene therapy
|
|
WO2016014794A1
(en)
|
2014-07-25 |
2016-01-28 |
Sangamo Biosciences, Inc. |
Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells
|
|
CA3172801A1
(en)
|
2015-06-12 |
2016-12-15 |
Lentigen Technology, Inc. |
Method to treat cancer with engineered t-cells
|
|
CN108883136A
(zh)
|
2016-02-12 |
2018-11-23 |
蓝鸟生物公司 |
Vcn增强子组合物及其使用方法
|
|
KR20250134722A
(ko)
|
2016-02-12 |
2025-09-11 |
블루버드 바이오, 인코포레이티드. |
Vcn 인핸서 조성물 및 이의 사용 방법
|
|
WO2018148502A1
(en)
|
2017-02-10 |
2018-08-16 |
Bluebird Bio, Inc. |
Vcn enhancer compositions and methods of using the same
|
|
FR3074189A1
(fr)
|
2017-11-30 |
2019-05-31 |
Assistance Publique - Hopitaux De Paris |
Methode de generation de greffons de cellules souches hematopoietiques
|